Becton Dickinson & Co.

BDX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $21.84B $20.18B $19.37B $18.87B $20.25B $17.12B $17.29B $15.98B
BD Medical $11.46B $10.07B $9.50B $8.84B $9.48B $8.68B $9.06B $8.62B
BD Life Sciences $5.17B $5.19B $5.13B $5.56B $6.53B $4.68B $4.30B $4.33B
BD Interventional $5.22B $4.98B $4.74B $4.46B $4.24B $3.76B $3.93B $3.04B
Corporate and Other $0 $-67.0M
Cost of Revenue $11.92B $11.05B $11.20B $10.39B $10.50B $9.28B $9.00B $8.71B
Gross Profit $9.93B $9.13B $8.17B $8.48B $9.75B $7.58B $8.29B $7.27B
Gross Margin 45.4% 45.2% 42.2% 44.9% 48.1% 44.3% 47.9% 45.5%
Operating Expenses
Research & Development $1.27B $1.19B $1.24B $1.26B $1.28B $1.04B $1.06B $1.00B
SG&A Expense $5.28B $4.86B $4.72B $4.71B $4.72B $4.19B $4.33B $4.02B
Operating Income $2.58B $2.40B $2.11B $2.28B $2.25B $912.0M $1.76B $1.51B
Operating Margin 11.8% 11.9% 10.9% 12.1% 11.1% 5.3% 10.2% 9.4%
Interest Expense $613.0M $528.0M $452.0M $398.0M $469.0M $528.0M $639.0M $706.0M
Pretax Income $1.88B $2.01B $1.66B $1.78B $1.69B $414.0M $1.18B $1.17B
Income Tax Expense $203.0M $300.0M $132.0M $148.0M $88.0M $62.0M $-57.0M $862.0M
Net Income $1.68B $1.71B $1.48B $1.78B $2.09B $874.0M $1.23B $311.0M
Net Margin 7.7% 8.4% 7.7% 9.4% 10.3% 5.1% 7.1% 1.9%
EPS (Basic) $5.83 $5.88 $4.97 $5.93 $6.92 $2.75 $4.01 $0.62
EPS (Diluted) $5.82 $5.86 $4.94 $5.88 $6.85 $2.71 $3.94 $0.60
Shares Outstanding (Basic) 287.6M 289.8M 286.3M 285.0M 289.3M 279.0M 269.9M 258.4M
Shares Outstanding (Diluted) 288.5M 291.0M 288.4M 287.4M 292.1M 282.4M 274.8M 264.6M
Dividends Per Share $4.16 $3.80 $3.64 $3.48 $3.32 $3.16 $3.08 $3.00
← Newer Page 1 of 3 Older →